Johnson & Johnson

Precision medicine, proven outcomes

New Brunswick, New Jersey, U.S.

Johnson & Johnson (J&J) is a global healthcare giant renowned for its extensive range of pharmaceutical, medical device, and consumer health products. The company operates with a unique "dual-engine" strategy, combining innovative medicine and medtech divisions, emphasizing innovation and strategic acquisitions to improve patient outcomes worldwide.

Johnson & Johnson hero image

Shareable draft

Check out Johnson & Johnson on @MedStartr Today Johnson & Johnson (J&J) is a global healthcare giant renowned for its extensive range of pharmaceutical, medical device, and consumer health products. The company operates with a unique "dual-engine" strategy, combining innovative medicine and medtech divisions, emphasizing innovation and strategic acquisitions to improve patient outcomes worldwide. #Immunology #Neuroscience #PulmonaryHypertension #InfectiousDiseases #Cardiopulmonary #Metabolism #Retina #AutoantibodyDiseases #Gastroenterology #Immunodermatology #Rheumatology #Orthopaedics #Surgery #Vision #MentalBehavioralHealth #CardiovascularDisease #RespiratoryDiseases #CancerOncology #MedicalDevices #MedMo #MedStartrVentures

https://www.medstartr.ai/s/EV3Qz_0oisw

Get Involved in Johnson & Johnson

How We Help

Core Technology

Robotics, Artificial Intelligence (AI), Machine Learning, Digital and Data Science solutions, Minimally Invasive Surgical solutions

Key Differentiators

Strong brand reputation, significant financial strength, extensive global reach, deep disease expertise, continuous heavy R&D investment, unique dual-engine structure (pharmaceuticals and medtech), Credo-Based Culture

Clinical Focus

Oncology, Immunology, Neuroscience, Pulmonary Hypertension, Infectious Diseases, Cardiopulmonary, Cardiovascular, Orthopaedics, Surgery, Vision

Target Customers

Hospitals, clinics, pharmacies, healthcare providers, individual consumers

Product Stage

Mature

Company Info

Business Model: B2B, B2C
Founded: 1886
Website: www.jnj.com

Disease Areas

Immunology Neuroscience Pulmonary Hypertension Infectious Diseases Cardiopulmonary Metabolism Retina Autoantibody Diseases Gastroenterology Immunodermatology Rheumatology Orthopaedics Surgery Vision Mental Health Cardiovascular Disease Respiratory Diseases Cancer & Oncology

Technologies

RoboticsMachine LearningDigital HealthData ScienceMinimally Invasive SurgeryAI & Machine Learning

Clinical & IP

🔬

Clinical Validation

27 FDA approvals in 2024. Rybrevant Faspro subcutaneous formulation approved Feb 2026 for EGFR-mutated NSCLC based on phase 3 PALOMA-3 trial. Nipocalimab submitted for myasthenia gravis based on Vivacity-MG3 Phase III program. TREMFYA positive phase 3b APEX data for psoriatic arthritis. 18 positive registrational studies completed in 2024.

🌐Website

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of Johnson & Johnson?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.